Price
13.49
+0%52W Range
Market Cap
₹31.60 Cr
Traded: ₹0.01 Cr (0.03%) 0.0x
Free Float: ₹13.43 Cr (0.07% of FF traded)
Volume · 60D trend
7.17 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Return | -- | -13.0% | -18.0% | -31.0% | -- | Decelerating |
| Sales | -- | +19.0% | +22.0% | -- | +0.0% | Stable |
| Profit | -- | +45.0% | +100.0% | -- | +146.0% | Accelerating |
| ROE | -- | +2.0% | +2.0% | -- | -- | Stable |
Quarterly Results
Dec 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 22 | 21 | 17 | 21 | 22 | 21 | 20 | 19 | 15 | 16 | 15 | 17 | 11 | 16 | 9 |
| Expenses | 21 | 20 | 16 | 20 | 21 | 20 | 20 | 18 | 14 | 15 | 14 | 16 | 10 | 15 | 9 |
| Operating Profit | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | -0 |
| OPM % | 4.1% | 4.2% | 9.9% | 8.0% | 3.4% | 2.9% | 2.9% | 5.9% | 5.8% | 4.2% | 8.0% | 6.0% | 7.1% | 4.6% | -2.3% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | -1 |
| Tax % | 23.7% | 8.1% | 25.4% | 25.4% | 30.3% | 47.8% | 25.0% | 25.4% | 26.5% | 60.0% | 32.9% | 25.0% | 25.0% | 25.7% | -22.0% |
| Net Profit | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | -0 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 0.1 | 0.1 | 0.4 | 0.4 | 0.1 | 0.1 | 0.1 | 0.3 | 0.2 | 0.1 | 0.3 | 0.3 | 0.2 | 0.2 | -0.3 |
| Sales Growth (YoY) | -0.3% | 1.1% | -14.9% | 13.7% | 47.0% | 29.9% | 33.2% | 9.5% | 34.2% | 0.7% | 77.3% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 5.2% | 20.6% | -18.7% | -3.3% | 6.7% | 1.6% | 8.6% | 25.0% | -5.7% | 4.1% | -10.8% | 53.2% | -29.3% | 83.3% | -- |
| OP Growth (YoY) | 20.0% | 45.9% | 193.2% | 54.1% | -13.8% | -9.0% | -52.0% | 6.7% | 8.7% | -8.2% | 715.0% | -- | -- | -- | -- |
| OP Growth (QoQ) | 1.1% | -48.6% | 1.2% | 128.0% | 23.0% | 3.4% | -46.8% | 27.6% | 29.9% | -45.5% | 18.3% | 30.0% | 9.6% | 465.0% | -- |
| Profit Growth (YoY) | 20.8% | 175.0% | 614.3% | 71.7% | -33.3% | -7.7% | -73.6% | -1.9% | 20.0% | -51.9% | 215.2% | 80.0% | 50.0% | -- | -- |
| EPS Growth (YoY) | 20.0% | 160.0% | 566.7% | 48.0% | -44.4% | -16.7% | -76.9% | -21.9% | 0.0% | -62.5% | 196.3% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -7.7% | -67.5% | 8.1% | 270.0% | 100.0% | -16.7% | -76.0% | 38.9% | 200.0% | -76.9% | -18.8% | 77.8% | 12.5% | 159.3% | -- |
| OP Margin | 4.1% | 4.2% | 9.9% | 8.0% | 3.4% | 2.9% | 2.9% | 5.9% | 5.8% | 4.2% | 8.0% | 6.0% | 7.1% | 4.6% | -2.3% |
| Net Margin | 1.3% | 1.6% | 5.8% | 4.3% | 1.1% | 0.6% | 0.7% | 2.8% | 2.4% | 0.8% | 3.5% | 3.1% | 2.7% | 1.7% | -5.3% |
| Material Cost % | 69.0% | 59.0% | 56.0% | 59.0% | 70.0% | 68.0% | 65.0% | 60.0% | 58.0% | 62.0% | 76.0% | 60.0% | 49.0% | 63.0% | 67.0% |
| Employee Cost % | 6.0% | 6.0% | 7.0% | 7.0% | 6.0% | 5.0% | 5.0% | 7.0% | 6.0% | 6.0% | 6.0% | 3.0% | 9.0% | 5.0% | 10.0% |
| P/S | 0.39 | 0.39 | 0.37 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 13.23 | 13.48 | 13.97 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 0.29 | 0.29 | 0.28 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Copy of Newspaper Publication made for submission of Unaudited Financial Results (Standalone & Consolidated) of the company for the quarter ended June 30, 2026.
Results
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, please find enclosed herewith the Un-Audited Financial Results (Standalone & Consolidated) ....
Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve the Un-audited Financial ....
Scrutinizer Report and Voting Results
Regularisation of Independent Directors
PROCEEDINGS OF EGM
Intimation
Newspaper Publication for Notice of EGM & E-Voting Information.
Notice of EGM
Appointment of Chief Financial Officer and Key Managerial Personnel of the Company.
Revised Resignation
Cessation of Chief Financial Officer and Key Managerial Personnel of the Company.
Intimation
Resignation of Independent Director
Intimation of Closure of trading window w.e.f 01 July 2026
Intimation of Newspaper Publication of Financial Results for the quarter and year ended March 31, 2026.
Audited Standalone and Consolidated Financial results for the FY 2025-26.
Annual Results for the FY 2025-26 and Corporate Update
Board of Directors of the Company, at its meeting held today i.e. Saturday, 30th May, 2026 which was commenced at 3:00 PM Via Video Conferencing, has inter alia considered and approved ....
Annual Secretarial Compliance Report for the FY 2025-26.
Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Audited Financial Results ....
Intimation
Press Release
Appointment of 3 Independent Directors on the board of Deccan Healthcare Limited.
Intimation
Intimation
Intimation of closure of Trading Window
Resignation of Ms. Samhitha Kandlakunta non-executive independent director with effect from 9 march 2026 and Ms. Karishma Patel non executive independent director with effect from 10 march 2026
News Paper Publication for Unaudited Financial Results for Quarter ended December 2025
Considered and Approved standalone and consolidated financial results for quarter ended 31.12.2025
Press Release of financial results for the quarter ended 31.12.2025
Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve Unaudited standalone and ....
Certificate under Reg 74(5) for Quarter ended Dec 2025
Resignation of CS and compliance officer.
Dear Sir/Madam, Pursuant to the Code of Conduct for Regulating, Monitoring & Reporting Trading by Insiders of the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, ....
Appointment of Ms Samhitha Kandalkunta and Ms Karishma Patel as the Independent Directors
Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/12/2025 ,inter alia, to consider and approve Appointment of Independent Directors
Disclosure under Regulation 30A of LODR - Resignation of Company Secretary / Compliance Officer
Resignation of Company Secretary / Compliance Officer
News Paper Publication for Unaudited Financial Results for Quarter ended September 2025
Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve 1. Unaudited Financial Results ....
Certificate under Reg 74(5)
E Voting Results 29th AGM 2024-25
Scrutinizer Report with Voting Results
Re Appointment of Ruchi Khattar as Independent Director of the Company
Press Release for 29th AGM of Company held today-30th September, 2025
29th Annual General Meeting of Deccan Health Care Limited held through VC on 30th September, 2025
Annual Report of 2024-25
Intimation of Closure of Trading Window
Annual Reports
7